Profile data is unavailable for this security.
About the company
Scandion Oncology A/S is a manufacturer of biological products. The Company was founded in May 2017 and is located in Copenhagen, Denmark. It focuses on modern onclogy, the treatment of cancers that have developed resistance to chemotherapy.
- Revenue in SEK (TTM)0.00
- Net income in SEK-56.46m
- Incorporated2017
- Employees4.00
- LocationScandion Oncology A/SFruebjergvej 3, Koebenhavn OeKOEBENHAVN 2100DenmarkDNK
- Websitehttps://scandiononcology.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Enorama Pharma AB | 670.00k | -42.47m | 134.25m | 5.00 | -- | 5.69 | -- | 200.38 | -1.03 | -1.03 | 0.0163 | 0.4271 | 0.0184 | 0.7583 | 0.6384 | 134,000.00 | -116.48 | -73.56 | -184.45 | -104.85 | -635.07 | 43.36 | -6,338.66 | -557.42 | 0.4626 | -605.70 | 0.02 | -- | -80.17 | -23.71 | -6.15 | -- | -- | -- |
Bioextrax AB publ | 1.63m | -22.16m | 143.33m | -- | -- | 7.83 | -- | 88.04 | -0.8034 | -0.8034 | 0.0588 | 0.5315 | 0.0686 | -- | 4.96 | -- | -93.29 | -86.39 | -102.02 | -110.84 | 3.62 | -- | -1,360.93 | -2,119.90 | -- | -- | 0.00 | -- | 420.51 | 24.40 | -15.21 | -- | 56.86 | -- |
Pila Pharma AB | 1.46m | -9.93m | 149.42m | 1.00 | -- | 22.43 | -- | 102.13 | -0.5304 | -0.5304 | 0.0767 | 0.28 | 0.1513 | -- | 6.11 | 1,463,020.00 | -102.68 | -108.88 | -122.66 | -121.45 | -127.88 | -42.67 | -678.73 | -1,577.64 | -- | -159.47 | 0.104 | -- | -22.21 | -- | 62.92 | -- | -- | -- |
Xintela AB | 377.00k | -49.24m | 153.09m | -- | -- | -- | -- | 406.08 | -0.1217 | -0.1217 | 0.0008 | -0.0136 | 0.0193 | -- | 0.0447 | -- | -252.59 | -181.06 | -- | -391.61 | 100.00 | -- | -13,061.54 | -235,894.00 | -- | -49.47 | -- | -- | -- | -45.54 | 18.32 | -- | -61.47 | -- |
Lipidor AB | 87.00k | -11.59m | 154.45m | -- | -- | -- | -- | 1,775.25 | -0.1049 | -0.1049 | 0.0008 | -0.0817 | 0.0122 | -- | 0.19 | -- | -162.65 | -59.41 | -- | -75.10 | -- | -- | -13,322.99 | -643.36 | -- | -- | -- | -- | 73.33 | -20.33 | 72.24 | -- | -- | -- |
Vo2 Cap Holding AB (publ) | 342.81m | 3.21m | 158.84m | 103.00 | 48.96 | 0.7183 | 3.11 | 0.4633 | 0.0607 | 0.0607 | 6.50 | 4.13 | 0.7493 | -- | 7.03 | 3,328,282.00 | 0.7023 | -0.2564 | 0.9347 | -0.3839 | 34.62 | 23.36 | 0.9373 | -0.2409 | -- | 1.18 | 0.1564 | -- | -26.09 | 85.65 | -57.92 | -- | -17.96 | -- |
Vivesto AB | 0.00 | -116.73m | 164.37m | 6.00 | -- | 0.868 | -- | -- | -0.219 | -0.219 | 0.00 | 0.352 | 0.00 | -- | -- | 0.00 | -44.08 | -- | -47.15 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -100.00 | -- | 64.80 | -- | -- | -- |
Lipum AB (publ) | 0.00 | -39.32m | 169.70m | 5.00 | -- | -- | -- | -- | -4.44 | -4.44 | 0.00 | -0.49 | 0.00 | -- | -- | 0.00 | -247.63 | -127.85 | -402.13 | -184.50 | -- | -- | -- | -293,228.70 | -- | -- | -- | -- | -- | -- | 2.38 | -- | -- | -- |
Scandion Oncology A/S | 0.00 | -56.46m | 180.00m | 4.00 | -- | 1.62 | -- | -- | -0.4246 | -0.4246 | 0.00 | 0.2643 | 0.00 | -- | -- | 0.00 | -74.59 | -- | -87.90 | -- | -- | -- | -- | -- | -- | -- | 0.0113 | -- | -- | -- | 48.89 | -- | -- | -- |
AlzeCure Pharma AB | 0.00 | -37.43m | 183.93m | 11.00 | -- | 9.31 | -- | -- | -0.5685 | -0.5685 | 0.00 | 0.2122 | 0.00 | -- | -- | 0.00 | -92.80 | -52.78 | -115.25 | -57.01 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 33.91 | -- | -- | -- |
Active Biotech AB publ | 0.00 | -44.80m | 185.93m | 8.00 | -- | 9.25 | -- | -- | -0.1651 | -0.1651 | 0.00 | 0.0556 | 0.00 | -- | -- | -- | -122.57 | -57.97 | -179.56 | -97.83 | -- | -- | -- | -1,454.61 | -- | -- | 0.1145 | -- | -- | -- | 21.54 | -- | -- | -- |
SenzaGen AB | -100.00bn | -100.00bn | 189.88m | 32.00 | -- | 2.89 | -- | -- | -- | -- | -- | 2.71 | -- | -- | -- | -- | -- | -25.84 | -- | -29.85 | -- | 68.62 | -- | -132.29 | 1.24 | -- | 0.0368 | -- | 19.39 | 90.32 | 11.30 | -- | -21.10 | -- |
Biovica International AB | 5.98m | -122.99m | 203.41m | 37.00 | -- | 1.62 | -- | 34.03 | -2.42 | -2.42 | 0.115 | 1.62 | 0.033 | -0.3053 | 8.43 | 170,800.00 | -67.80 | -42.10 | -74.69 | -46.33 | 110.09 | 277.88 | -2,057.41 | -2,149.68 | 7.10 | -- | 0.057 | -- | 65.43 | 4.44 | -84.14 | -- | -20.20 | -- |
Kancera AB | 0.00 | -60.35m | 208.20m | 5.00 | -- | 2.22 | -- | -- | -0.7267 | -0.7267 | 0.00 | 0.7749 | 0.00 | -- | -- | 0.00 | -52.92 | -54.82 | -65.84 | -66.21 | -- | 96.28 | -- | -7,249.06 | -- | -- | 0.00 | -- | -- | -- | -23.64 | -- | -- | -- |
Abliva AB | 137.00k | -97.60m | 222.38m | 6.00 | -- | 3.29 | -- | 1,623.20 | -0.0924 | -0.0924 | 0.0001 | 0.05 | 0.0013 | -- | 0.0045 | -- | -88.80 | -74.59 | -96.20 | -86.98 | -24,869.34 | -- | -71,240.15 | -65,958.89 | -- | -- | 0.00 | -- | 341.94 | 93.89 | -12.02 | -- | -19.74 | -- |
Data as of Jun 14 2024. Currency figures normalised to Scandion Oncology A/S's reporting currency: Swedish Krona SEK